Nagy, A.; Májer, R.; Boczán, J.; Sipka, S., Jr.; Szabó, A.; Enyedi, E.E.; Tatai, O.; Fagyas, M.; Papp, Z.; Csiba, L.;
et al. Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives. Biomedicines 2023, 11, 3323.
https://doi.org/10.3390/biomedicines11123323
AMA Style
Nagy A, Májer R, Boczán J, Sipka S Jr., Szabó A, Enyedi EE, Tatai O, Fagyas M, Papp Z, Csiba L,
et al. Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives. Biomedicines. 2023; 11(12):3323.
https://doi.org/10.3390/biomedicines11123323
Chicago/Turabian Style
Nagy, Attila, Réka Májer, Judit Boczán, Sándor Sipka, Jr., Attila Szabó, Enikő Edit Enyedi, Ottó Tatai, Miklós Fagyas, Zoltán Papp, László Csiba,
and et al. 2023. "Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives" Biomedicines 11, no. 12: 3323.
https://doi.org/10.3390/biomedicines11123323
APA Style
Nagy, A., Májer, R., Boczán, J., Sipka, S., Jr., Szabó, A., Enyedi, E. E., Tatai, O., Fagyas, M., Papp, Z., Csiba, L., & Tóth, A.
(2023). Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives. Biomedicines, 11(12), 3323.
https://doi.org/10.3390/biomedicines11123323
